Antiplatelet agents and arterial thrombosis

Cardiology Clinics
Henny H Billett

Abstract

There is an increase in arterial thrombotic events in the elderly. Elderly patients are more likely to have associated diseases, such as diabetes, hypertension and hypercholesterolemia, and when age is confounded by these other predisposing factors, the risk of an arterial ischemic event increases disproportionately. Antithrombotic therapy for geriatric patients is underused, even when one adjusts for potential drug contraindications. This article focuses on the action of the currently available antiplatelet agents--aspirin, clopidogrel, and glycoprotein IIb/IIIa (GPIIb/IIIa) receptor antagonists, and assesses their effects in different disease states, with special attention to data that examine the geriatric population.

References

Oct 31, 1991·The New England Journal of Medicine·UNKNOWN Dutch TIA Trial Study GroupAnet van Latum
Jul 20, 1989·The New England Journal of Medicine·UNKNOWN Steering Committee of the Physicians' Health Study Research Group
Jan 30, 1988·British Medical Journal·R PetoS Norton
Dec 1, 1994·Stroke; a Journal of Cerebral Circulation·C M HelgasonL D Brace
May 23, 1998·The New England Journal of Medicine·UNKNOWN Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators
Jul 27, 1999·Journal of Hypertension·B WaeberG T McInnes
Jun 15, 2000·The New England Journal of Medicine·C L BennettH M Tsai
Jul 18, 2000·Journal of the American College of Cardiology·D C SaneR M Califf
Oct 14, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·G HelftJ H Chesebro
Jul 10, 2001·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·G SyrbeT Herzog
Jul 27, 2001·The American Journal of Cardiology·P A GumE J Topol
Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Aug 25, 2001·Lancet·S R MehtaUNKNOWN Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators
Sep 19, 2001·British Journal of Clinical Pharmacology·A A WeberK Schrör
Dec 26, 2001·The New England Journal of Medicine·F Catella-LawsonG A FitzGerald
Jan 16, 2002·Annals of Internal Medicine·UNKNOWN U.S. Preventive Services Task Force
Jan 17, 2002·The New England Journal of Medicine·J P MohrUNKNOWN Warfarin-Aspirin Recurrent Stroke Study Group
Nov 19, 2002·JAMA : the Journal of the American Medical Association·Steven R SteinhublUNKNOWN CREDO Investigators. Clopidogrel for the Reduction of Events During Observation
Jan 16, 2003·Journal of Neurology·K GrundmannH Topka
Aug 13, 2003·Journal of Thrombosis and Haemostasis : JTH·C Patrono
Sep 25, 2003·Archives of Internal Medicine·Rachel S EidelmanCharles H Hennekens

❮ Previous
Next ❯

Citations

May 14, 2009·Vascular Health and Risk Management·Filippo Marzot, Vittorio Pengo
Nov 3, 2009·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Pawan VasudevaDivakar Dalela
Oct 8, 2009·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Hideki ItoGoro Miyakoda
May 20, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Stacy S ShordAmina George
Mar 6, 2009·American Journal of Therapeutics·Inna ShalitoVictor Serebruany

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Clinics in Geriatric Medicine
Henny H Billett
Hematology/oncology Clinics of North America
D C Calverley, G J Roth
Journal of Thrombosis and Haemostasis : JTH
D R PhillipsP Andre
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Hao DuanXiaojiang Sun
© 2022 Meta ULC. All rights reserved